Omni Los Angeles Hotel
Los Angeles, California

January 27, 2018

SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation/CME Surveys
>Registration
>Hotel Reservations

 

Supported by:
GOOD SAMARITAN HOSPITAL
Los Angeles, CA


Affiliated With:
AMERICAN COLLEGE OF CARDIOLOGY



THIRD ANNUAL SYMPOSIUM

Contemporary Management of
Cardiovascular Disease in Women

January 27, 2018

IMPORTANT CME CREDIT NOTICE
CME Certificates will be issued digitally after Speaker and Symposium Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration.

Surveys will be accessible online the day of the symposium and for 3 weeks following. You must complete the process by February 18, 2018 in order to receive your certificate. Certificates will be available online until October 1, 2018 and are printable directly from the website.

ACCREDITATION
This Live activity, Third Annual Contemporary Management of Cardiovascular Disease in Women, with a beginning date of January 27, 2018 is being reviewed for up to TBD Prescribed credit(s) by an accrediting organization. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COURSE DESCRIPTION
Heart disease is the leading cause of death in women in the US and accounts for more deaths each year than all of the other causes combined. In women of racial or ethnic minority the rates of death are even higher. One in three women will die of some form of heart or vascular disease. However, only one-third of women are aware of this statistic and only half would call 911 if they had symptoms of a heart attack. Compared to men, women are less likely to receive standard of care of treatment for chest pain, less likely to be referred to a cardiologist, and less likely to be admitted to the hospital. It is our mission to educate healthcare providers about the risk of heart disease in women and empower them to be advocates for women's cardiovascular health.

This educational symposium will define risk factors for cardiovascular disease in women and how they differ from men, address lifestyle changes for modifiable risk factors, including diet modification and management of obesity, and address the impact of cardiovascular disease in women worldwide. Discussions will include women-specific cardiovascular risk assessment in the setting of pregnancy and management of pregnancy complicated by high-risk cardiovascular diseases, conditions primarily affecting women, such as Pulmonary Arterial Hypertension and Dysautonomia, and advances in the management of dyslipidemia, atrial fibrillation and open artery myocardial infarction. State of the art therapies for structural heart disease, with an emphasis on outcomes in women, will be included.

This symposium will educate healthcare providers on gender-specific approaches in prevention, diagnosis, treatment and outcomes of women with a broad range of cardiovascular diseases.

PROGRAM OBJECTIVES
1. Understand the impact of cardiovascular disease in women, including current incidence and prevalence
2. Review the risks, presentation and current treatment guidelines for treatment of CAD in women
3. Explore the diagnosis and management of ischemia and myocardial infarction in women without obstructive CAD
4. Discuss preconception counseling for women with various existing cardiovascular disorders
5. Understand the management of women with high-risk cardiovascular disorders during pregnancy
6. Review current management guidelines for hyperlipidemia and discuss newer, non-statin therapies
7. Discuss updates on lifestyle modification, including diet and obesity guidelines
8. Understand the differential, diagnosis and management of dysautonomia
9. Discuss the initial evaluation and management of pulmonary arterial hypertension
10. Review the cardiovascular effects of cancer therapies in women
11. Review pharmacologic and non-pharmacologic therapies for prevention of thromboembolic complications in atrial fibrillation
12. Review updated indications and compare the current outcomes in transcatheter vs. surgical aortic valve replacement in women
13. Examine gender-related outcomes of percutaneous mitral valve repair

NEEDS ASSESSMENT
Heart disease is the leading cause of death in women in the US and accounts for more deaths each year than all of the other causes combined. In women of racial or ethnic minority the rates of death are even higher. One in three women will die of some form of heart or vascular disease. However, only one-third of women are aware of this statistic and only half would call 911 if they had symptoms of a heart attack. Compared to men, women are less likely to receive standard of care of treatment for chest pain, less likely to be referred to a cardiologist, and less likely to be admitted to the hospital. It is our mission to educate healthcare providers about the risk of heart disease in women and empower them to be advocates for women's cardiovascular health.

This educational symposium will define risk factors for cardiovascular disease in women and how they differ from men, address lifestyle changes for modifiable risk factors, including diet modification and management of obesity, and address the impact of cardiovascular disease in women worldwide.

TARGET AUDIENCE
This program has been designed to provide primary care physicians, internists, cardiologists, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers with the necessary information to increase knowledge and awareness of cardiovascular disease in women with the goal of improving patient care.

FACULTY DISCLOSURE
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individualís control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speakerís outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.

CULTURAL AND LINGUISTIC COMPENTENCY
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patientís primary language. Cultural and linguistic competency was incorporated into the planning of this activity.